HOPSTEM BIOTECHNOLOGY INC.
πΊπΈUnited States
- Country
- πΊπΈUnited States
- Ownership
- Holding
- Established
- 2017-01-16
- Employees
- 1
- Market Cap
- -
- Website
- http://www.hopstem.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (100.0%)A Safety and Tolerability Study of Human Forebrain Neural Progenitor Cells Injection (hNPC01) in Subjects With Chronic Ischemic Stroke
- First Posted Date
- 2024-03-07
- Last Posted Date
- 2024-03-07
- Lead Sponsor
- Hopstem Biotechnology Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT06299033
- Locations
- π¨π³
XiangYa Hospital, Changsha, Hunan, China
News
No news found